{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:38:48Z","timestamp":1778582328704,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ10036"],"award-info":[{"award-number":["2023JJ10036"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PhD Scientific Research Start-up Fund of University of South China","award":["200XQD075"],"award-info":[{"award-number":["200XQD075"]}]},{"name":"Scientific Research Project of Hunan Department of Education","award":["22B0452"],"award-info":[{"award-number":["22B0452"]}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduates","doi-asserted-by":"crossref","award":["CX20220975"],"award-info":[{"award-number":["CX20220975"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National College Student Innovation and Entrepreneurship Training Program","award":["210XCX536"],"award-info":[{"award-number":["210XCX536"]}]},{"name":"National College Student Innovation and Entrepreneurship Training Program","award":["220XCX079"],"award-info":[{"award-number":["220XCX079"]}]},{"name":"National College Student Innovation and Entrepreneurship Training Program","award":["220XCX254"],"award-info":[{"award-number":["220XCX254"]}]},{"name":"National College Student Innovation and Entrepreneurship Training Program","award":["220XCX486"],"award-info":[{"award-number":["220XCX486"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00277-023-05592-w","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T04:38:16Z","timestamp":1703651896000},"page":"1293-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells"],"prefix":"10.1007","volume":"103","author":[{"given":"Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanyou","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-5377","authenticated-orcid":false,"given":"Jiliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"key":"5592_CR1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364:1046\u20131060","journal-title":"N Engl J Med"},{"key":"5592_CR2","doi-asserted-by":"crossref","unstructured":"Elbezanti WO, Challagundla KB, Jonnalagadda SC et al (2023) Past, present, and a glance into the future of multiple myeloma treatment. Pharmaceuticals (Basel) 16(3):415","DOI":"10.3390\/ph16030415"},{"key":"5592_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1714678","volume":"378","author":"MV Mateos","year":"2018","unstructured":"Mateos MV, Dimopoulos MA, Cavo M et al (2018) Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma. N Engl J Med 378:518\u2013528","journal-title":"N Engl J Med"},{"key":"5592_CR4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 97:1086\u20131107","journal-title":"Am J Hematol"},{"key":"5592_CR5","doi-asserted-by":"crossref","unstructured":"Rajkumar SV, Kumar S (2020) Multiple myeloma current treatment algorithms. Blood Cancer J 10(9):94","DOI":"10.1038\/s41408-020-00359-2"},{"key":"5592_CR6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2009-11-252429","volume":"115","author":"S Giralt","year":"2010","unstructured":"Giralt S (2010) A TAD better for myeloma therapy? Blood 115:1109\u20131110","journal-title":"Blood"},{"key":"5592_CR7","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3390\/jcm9113554","volume":"9","author":"H Gardeney","year":"2020","unstructured":"Gardeney H, Bobin A, Gruchet C et al (2020) Three drug combinations in the treatment of fit elderly multiple myeloma patients. J Clin Med 9:3554","journal-title":"J Clin Med"},{"key":"5592_CR8","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41375-019-0561-2","volume":"33","author":"AH Bazarbachi","year":"2019","unstructured":"Bazarbachi AH, Al Hamed R, Malard F et al (2019) Relapsed refractory multiple myeloma: a comprehensive overview. Leukemia 33:2343\u20132357","journal-title":"Leukemia"},{"key":"5592_CR9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/1568026621666211105094939","volume":"22","author":"A Rauf","year":"2022","unstructured":"Rauf A, Abu-Izneid T, Thiruvengadam M et al (2022) Garlic (allium sativum L.): its chemistry, nutritional composition, toxicity, and anticancer properties. Curr Top Med Chem 22:957\u2013972","journal-title":"Curr Top Med Chem"},{"key":"5592_CR10","doi-asserted-by":"crossref","unstructured":"Mitra S, Das R, Emran TB et al (2022) Diallyl disulfide: a bioactive garlic compound with anticancer potential. Front Pharmacol 13:943967","DOI":"10.3389\/fphar.2022.943967"},{"key":"5592_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/carcin\/17.4.669","volume":"17","author":"SG Sundaram","year":"1996","unstructured":"Sundaram SG, Milner JA (1996) Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 17:669\u2013673","journal-title":"Carcinogenesis"},{"key":"5592_CR12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.fct.2019.01.023","volume":"125","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Kang S, Kim DY et al (2019) Diallyl disulfide (DADS) boosts TRAIL-Mediated apoptosis in colorectal cancer cells by inhibiting Bcl-2. Food Chem Toxicol 125:354\u2013360","journal-title":"Food Chem Toxicol"},{"key":"5592_CR13","first-page":"772","volume":"56","author":"H Ling","year":"2020","unstructured":"Ling H, Ji X, Lei Y et al (2020) Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1\/ROCK1\/LIMK1 pathway in leukemia cells. Int J Oncol 56:772\u2013782","journal-title":"Int J Oncol"},{"key":"5592_CR14","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3892\/or.2014.3361","volume":"32","author":"X Yin","year":"2014","unstructured":"Yin X, Zhang R, Feng C, Zhang J, Liu D, Xu K, Wang X, Zhang S, Li Z, Liu X, Ma H (2014) Diallyl disulfide induces G2\/M arrest and promotes apoptosis through the p53\/p21 and MEK-ERK pathways in human esophageal squamous cell carcinoma. Oncol Rep 32:1748\u20131756","journal-title":"Oncol Rep"},{"key":"5592_CR15","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.2147\/OTT.S208738","volume":"12","author":"L Xia","year":"2019","unstructured":"Xia L, Lin J, Su J et al (2019) Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition. Onco Targets Ther 12:5713\u20135728","journal-title":"Onco Targets Ther"},{"key":"5592_CR16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/mnfr.201400668","volume":"59","author":"J Huang","year":"2015","unstructured":"Huang J, Yang B, Xiang T et al (2015) Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the \u03b2-catenin signaling pathway. Mol Nutr Food Res 59:1063\u20131075","journal-title":"Mol Nutr Food Res"},{"key":"5592_CR17","first-page":"2797","volume":"39","author":"B Su","year":"2018","unstructured":"Su B, Su J, Zeng Y et al (2018) Diallyl disulfide inhibits TGF-\u03b21-induced upregulation of Rac1 and \u03b2-catenin in epithelial-mesenchymal transition and tumor growth of gastric cancer. Oncol Rep 39:2797\u20132806","journal-title":"Oncol Rep"},{"key":"5592_CR18","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1002\/jcb.28003","volume":"120","author":"Y Li","year":"2019","unstructured":"Li Y, Wang Z, Li J, Sang X (2019) Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134. J Cell Biochem 120:7286\u20137296","journal-title":"J Cell Biochem"},{"key":"5592_CR19","doi-asserted-by":"crossref","unstructured":"Zhang XN, Zhao N, Guo FF et al (2022) Diallyl disulfide suppresses the lipopolysaccharide-driven inflammatory response of macrophages by activating the Nrf2 pathway. Food Chem Toxicol 159:112760","DOI":"10.1016\/j.fct.2021.112760"},{"key":"5592_CR20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fct.2013.04.001","volume":"57","author":"L Yi","year":"2013","unstructured":"Yi L, Su Q (2013) Molecular mechanisms for the anti-cancer effects of diallyl disulfide. Food Chem Toxicol 57:362\u2013370","journal-title":"Food Chem Toxicol"},{"key":"5592_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpha.2021.11.004","volume":"12","author":"R Malla","year":"2022","unstructured":"Malla R, Marni R, Chakraborty A, Kamal MA (2022) Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. J Pharm Anal 12:221\u2013231","journal-title":"J Pharm Anal"},{"key":"5592_CR22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/tox.23748","volume":"38","author":"T Hui","year":"2023","unstructured":"Hui T, Yiling J, Guangqun C et al (2023) Diallyl disulfide downregulating RhoGDI2 induces differentiation and inhibit invasion via the Rac1\/Pak1\/LIMK1 pathway in human leukemia HL-60 cells. Environ Toxicol 38:1063\u20131077","journal-title":"Environ Toxicol"},{"key":"5592_CR23","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/pharmaceutics14122582","volume":"14","author":"ART Machado","year":"2022","unstructured":"Machado ART, Tuttis K, Santos PWDS et al (2022) Diallyl disulfide induces chemosensitization to sorafenib, autophagy, and cell cycle arrest and inhibits invasion in hepatocellular carcinoma. Pharmaceutics 14:2582","journal-title":"Pharmaceutics"},{"key":"5592_CR24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/pharmaceutics14020236","volume":"14","author":"F Alrumaihi","year":"2022","unstructured":"Alrumaihi F, Khan MA, Babiker AY et al (2022) The effect of liposomal diallyl disulfide and oxaliplatin on proliferation of colorectal cancer cells: in vitro and in silico analysis. Pharmaceutics 14:236","journal-title":"Pharmaceutics"},{"key":"5592_CR25","doi-asserted-by":"crossref","first-page":"120369","DOI":"10.1016\/j.lfs.2022.120369","volume":"294","author":"NM Abdel-Hamid","year":"2022","unstructured":"Abdel-Hamid NM, Abass SA, Eldomany RA et al (2022) Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats. Life Sci 294:120369","journal-title":"Life Sci"},{"key":"5592_CR26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2010.12.004","volume":"143","author":"I Verbrugge","year":"2010","unstructured":"Verbrugge I, Johnstone RW, Smyth MJ (2010) SnapShot: extrinsic apoptosis pathways. Cell 143:1192-1192.e1192","journal-title":"Cell"},{"key":"5592_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","volume":"41","author":"Q Cui","year":"2018","unstructured":"Cui Q, Wang JQ, Assaraf YG et al (2018) Modulating ROS to overcome multidrug resistance in cancer. Drug Resist Updat 41:1\u201325","journal-title":"Drug Resist Updat"},{"key":"5592_CR28","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K (2021) Reactive oxygen species in cancer: current findings and future directions. Cancer Sci 112:3945\u20133952","journal-title":"Cancer Sci"},{"key":"5592_CR29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52:192\u2013203","journal-title":"Exp Mol Med"},{"key":"5592_CR30","doi-asserted-by":"crossref","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD (2019) ROS and the DNA damage response in cancer. Redox Biol 25:101084","DOI":"10.1016\/j.redox.2018.101084"},{"key":"5592_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.fct.2008.10.032","volume":"47","author":"JS Yang","year":"2009","unstructured":"Yang JS, Chen GW, Hsia TC et al (2009) Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade and mitochondrial-dependent pathways. Food Chem Toxicol 47:171\u2013179","journal-title":"Food Chem Toxicol"},{"key":"5592_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mrfmmm.2005.02.026","volume":"579","author":"XJ Wu","year":"2005","unstructured":"Wu XJ, Kassie F, Mersch-Sundermann V (2005) The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells. Mutat Res 579:115\u2013124","journal-title":"Mutat Res"},{"key":"5592_CR33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.pharep.2017.03.006","volume":"69","author":"V Saini","year":"2017","unstructured":"Saini V, Manral A, Arora R et al (2017) Novel synthetic analogs of diallyl disulfide triggers cell cycle arrest and apoptosis via ROS generation in MIA PaCa-2 cells. Pharmacol Rep 69:813\u2013821","journal-title":"Pharmacol Rep"},{"key":"5592_CR34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/yea.1503","volume":"24","author":"KM Lemar","year":"2007","unstructured":"Lemar KM, Aon MA, Cortassa S et al (2007) Diallyl disulphide depletes glutathione in Candida albicans: oxidative stress-mediated cell death studied by two-photon microscopy. Yeast 24:695\u2013706","journal-title":"Yeast"},{"key":"5592_CR35","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC (2018) Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 217:2291\u20132298","journal-title":"J Cell Biol"},{"key":"5592_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","volume":"18","author":"J Xia","year":"2017","unstructured":"Xia J, Xu H, Zhang X et al (2017) Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid. EBioMedicine 18:41\u201349","journal-title":"EBioMedicine"},{"key":"5592_CR37","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1038\/sj.onc.1208949","volume":"24","author":"P Gomez-Bougie","year":"2005","unstructured":"Gomez-Bougie P, Oliver L, Le Gouill S et al (2005) Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1\/Bim complex. Oncogene 24:8076\u20138079","journal-title":"Oncogene"},{"key":"5592_CR38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/ajcn\/84.5.1027","volume":"84","author":"C Galeone","year":"2006","unstructured":"Galeone C, Pelucchi C, Levi F et al (2006) Onion and garlic use and human cancer. Am J Clin Nutr 84:1027\u20131032","journal-title":"Am J Clin Nutr"},{"key":"5592_CR39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17:395\u2013417","journal-title":"Nat Rev Clin Oncol"},{"key":"5592_CR40","first-page":"2791","volume":"28","author":"YT Lin","year":"2008","unstructured":"Lin YT, Yang JS, Lin SY et al (2008) Diallyl disulfide (DADS) induces apoptosis in human cervical cancer Ca Ski cells via reactive oxygen species and Ca2+-dependent mitochondria-dependent pathway. Anticancer Res 28:2791\u20132799","journal-title":"Anticancer Res"},{"key":"5592_CR41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jnutbio.2009.01.015","volume":"21","author":"NS Nagaraj","year":"2010","unstructured":"Nagaraj NS, Anilakumar KR, Singh OV (2010) Diallyl disulfide causes caspase-dependent apoptosis in human cancer cells through a Bax-triggered mitochondrial pathway. J Nutr Biochem 21:405\u2013412","journal-title":"J Nutr Biochem"},{"key":"5592_CR42","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1080\/15384101.2015.1104438","volume":"14","author":"C Di","year":"2015","unstructured":"Di C, Sun C, Li H et al (2015) Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73 \/\u0394Np73. Cell Cycle 14:3725\u20133733","journal-title":"Cell Cycle"},{"key":"5592_CR43","doi-asserted-by":"crossref","first-page":"11735","DOI":"10.1158\/0008-5472.CAN-05-3067","volume":"65","author":"G Filomeni","year":"2005","unstructured":"Filomeni G, Aquilano K, Rotilio G, Ciriolo MR (2005) Glutathione-related systems and modulation of extracellular signal-regulated kinases are involved in the resistance of AGS adenocarcinoma gastric cells to diallyl disulfide-induced apoptosis. Cancer Res 65:11735\u201311742","journal-title":"Cancer Res"},{"key":"5592_CR44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-2952(01)00860-7","volume":"63","author":"KB Kwon","year":"2002","unstructured":"Kwon KB, Yoo SJ, Ryu DG et al (2002) Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem Pharmacol 63:41\u201347","journal-title":"Biochem Pharmacol"},{"key":"5592_CR45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3324\/haematol.11435","volume":"92","author":"MA Dimopoulos","year":"2007","unstructured":"Dimopoulos MA, Souliotis VL, Anagnostopoulos A et al (2007) Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma. Haematologica 92:1505\u20131512","journal-title":"Haematologica"},{"key":"5592_CR46","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14737140.7.7.945","volume":"7","author":"P Falco","year":"2007","unstructured":"Falco P, Bringhen S, Avonto I et al (2007) Melphalan and its role in the management of patients with multiple myeloma. Expert Rev Anticancer Ther 7:945\u2013957","journal-title":"Expert Rev Anticancer Ther"},{"key":"5592_CR47","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/jcm10091841","volume":"10","author":"A Poczta","year":"2021","unstructured":"Poczta A, Rogalska A, Marczak A (2021) Treatment of multiple myeloma and the role of melphalan in the era of modern therapies-current research and clinical approaches. J Clin Med 10:1841","journal-title":"J Clin Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05592-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T10:07:55Z","timestamp":1710410875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05592-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["5592"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05592-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}